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  RESUMO	  
Objetivo: Avaliar a eficácia de hipoclorito 1% como um agente de desinfecção ambiental para controlar Acinetobacter 
em um hospital onde este microrganismo é endêmico. Métodos: Uma avaliação foi realizada em três diferentes períodos: 10 
meses antes, durante 3 meses e 5 meses após a intervenção com a higienização do ambiente, usando hipoclorito de 1% em 
todas as unidades do hospital. Os dados sobre infecção (pneumonia, infecção do trato urinário e bacteremia) foram 
apresentados como número por 1000 pacientes-dia. Resultados: A taxa de infecção Acinetobacter eram 16,7 por 1000 
pacientes-dia antes da intervenção, 5,1 por 1000 pacientes-dia durante a intervenção e 25,0 por 1000 pacientes-dia de cinco 
meses após a intervenção de hipoclorito. A intervenção hipoclorito resultou numa redução significativa na infecção por 
Acinetobacter em todos os sítios (urinária, bacteremia e pneumonia) (p <0,05). Conclusão: hipoclorito foi eficaz na redução 
temporária da taxa de Acinetobacter infecção. 
	   Palavras-­‐Chaves:	  Hipoclorito.	  Controle	  de	  Infecção.	  Infecção.	  Acinetobacter.	  Surto.	  
 
ABSTRACT	  
Objective: Evaluate the effectiveness of 1% hypochlorite as an environmental disinfection agent to control 
Acinetobacter infection in a hospital where this microorganism is endemic. Methods: An interventional prospective at three 
different periods: 10 months before, 3 months during and 5 months after intervention with environmental hygienization using 
1% hypochlorite in all units of the hospital. The normal routine for infection control remained the same during the intervention. 
Data on infection (pneumonia, bacteremia and urinary tract infection) were presented as number per 1000 patient-days. 
Results:  The rate of Acinetobacter infection were 16.7 per 1000 patient-days before intervention, 5.1 per 1000 patient-days 
during intervention and 25.0 per 1000 patient-days five months after hypochlorite intervention. The hypochlorite intervention 
resulted in a significant reduction in Acinetobacter infection, including all sites (urinary, bacteremia and pneumonia) (p < 0.05). 
Conclusion: Hypochlorite was effective in reducing the rate of Acinetobacter infection during the disinfection. 
Keywords: Hypochlorite. Infection Control. Infection. Acinetobacter. Outbreak
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INTRODUCTION	  
	  
In the last two decades, the incidence of 
infections caused by multi-drug resistant bacteria has 
increased at an alarming rate1. Acinetobacter baumannii 
has been recognized as the leading cause of infection in 
Brazilian hospitals, and the prevalence of colonization has 
increased around the world2. Acinetobacter infection has 
posed some challenges to physicians, including attributed 
mortality, few therapeutic options, unresponsiveness to 
available drugs and difficulty in defining infection and 
colonization3,4. 
Several approaches have been taken in attempts 
to control Acinetobacter infection. Successful measures 
have been described in controlling outbreaks3. However, 
controlling endemic Acinetobacter infection in hospital is 
very difficult. The existing approaches consist of 
environmental disinfection using potent products together 
with an intensive educational program that promotes hand 
hygiene and contact isolation with cohort, even with 
selective decontamination1,3,5,6. 
The aim of our study was to evaluate the 
effectiveness of environmental disinfection with 1% 
hypochlorite as an isolated measure to control endemic 
Acinetobacter infection and colonization in a hospital. 
	  
METHODS 
	  
Local 
This study was performed in a 660-bed university 
hospital in Curitiba, a city in Southern Brazil. An 
observational prospective study was performed after 
establishment of a new hygienization environment routine 
using 1% hypochlorite. Quaternary ammonium compounds 
have been used for hygienization in our hospital. The 
normal routine to control infection remained the same 
during the hygiene modification. There were no other 
interventions, such as educational campaign, new 
orientation, hand hygiene orientation or other measures to 
modify the current routine protocol to control infection. The 
data were collected at three distinct phases during January 
2008 to July 2009. The first phase was ten months prior to 
the routine modification. The second phase was three 
months during the hypochlorite application. The last phase 
was five months after the protocol. Active surveillance of 
colonization was not performed during the study (rectal, 
nasal or auxiliary swabs). Cultures from these sites were 
excluded from the study. 
Protocol 
The protocol for 1% hypochlorite application 
consisted cleaning of the following: 1) floor and walls; 2) 
beds; 3) tables and chairs; 4) windows and doors; 5) entire 
bathrooms. These places were cleaned daily. All units of 
the hospital were also included, such as surgical rooms 
where terminal decontamination with hypochlorite was 
used between each surgery, laboratory, all intensive care 
units, all beds in the entire hospital and the floor of 
administrative areas. In areas of intensive circulation, 
cleaning was performed at night. This dose of hypochlorite 
(1%) is approved by ANVISA (National Agency of Sanitary 
Vigilance).  
Acinetobacter infection 
The identification of Acinetobacter was performed 
using biochemical tests. Susceptibility test were performed 
as previously published in the Clinical and Laboratory 
Standards Institute (CLSI)7. Hospital infection was defined 
according to CDC (Centers for Disease Control and 
Prevention) criteria. The infection rate was determined by 
1000 patient-days. We included ventilator-associated 
pneumonia, bloodstream infection and urinary tract 
infection for infection rate analysis. Surgical site infections 
and other infections were excluded due to the difficulty in 
differentiating between infection and colonization. A 
patient with positive Acinetobacter culture was only 
included once. 
Fingerprinting of the isolates using the 
DiversiLab system 
We included five samples of A. baumannii from 
different sites (two from blood culture and three from 
central venous catheter) of the patients from 2008 during 
the first 10 months before the intervention. Only five 
strains were stored in this period, and all of them were 
carbapenem resistant and showed the same susceptibility 
pattern.  
The isolates were fingerprinted using the rep-PCR 
automated in the DiversiLab system (bioMèrieux). DNA was 
extracted from a bacterial suspension in physiologic saline 
and electrophoresed in 1.5% agarose and stained with 
Sybrsafe (Invitrogen). The fingerprinting of the isolates was 
performed using Acinetobacter Kit (DiversiLab). The 
samples were loaded in a chip and run using the Agilent 
2100 Bioanalyzer (Agilent Technologies) as previous 
performed and described8.  
Adverse effects 
We analyzed the most common complaints of 
heath care workers using a questionnaire with objective 
answers at the end of the protocol to avoid behavioral 
modifications. The cleaning staff was not analyzed. 
Statistical Analysis 
Data about infection and colonization were 
expressed as number per 1000-patient-days and 
comparison along the time using non-parametric T test for 
the three phases. 
RESULTS 
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The total number of admissions per period of the 
study is described in Table 1. A total of 24,931 cultures 
from different sites were performed, excluding rectal, 
auxiliary and nasal cultures. From the cultures, 26.1% were 
positive, Acinetobacter spp. was identified in 560 (8.1% of 
total).  
Table 1. Description of Acinetobacter infection and 
colonization during three periods of sodium 
hypochlorite hygienization 
 
The total number of infections during the three 
periods is indicated in Table 1. During the first period, the 
rate of bloodstream infection was 4.6 per 1000 patient-
days, the rate of urinary tract infection was 4.3 per 1000 
patient-days and the rate of ventilator-associated 
pneumonia was 8.1 per 1000 ventilator-days. During the 
second period (during intervention), the rate of 
bloodstream infection was 1.1 per 1000 patient-days, the 
rate of urinary tract infection was 1.1 per 1000 patient-
days and the rate of ventilator-associated pneumonia was 
4.0 per 1000 ventilator-days. During the third period (after 
intervention), the rate of bloodstream infection was 3.4 per 
1000 patient-days, the rate of urinary tract infection was 
12.0 per 1000 patient-days and the rate of ventilator-
associated pneumonia was 6.50 per 1000 ventilator-days. 
A comparison of infection types during all three phases is 
depicted in Figure 1. Intervention with hypochlorite showed 
a significant reduction in Acinetobacter infection of all 
types (urinary, bacteremia and pneumonia) (P < 0.05). 
However, during the third period after interruption of 
hypochlorite usage, the infection rate was similar to the 
first period, which was before intervention. The 
fingerprinting showed that the five samples tested were not 
similar (figure 2). 
 
 
 
Figure 1. Acinetobacter infection rate before (A),  during 
(B) and after (C) hypochlorite hygienization. * p < 0.05 
 
Adverse effects 
One-hundred ninety-seven healthcare workers 
were questioned for any signs or symptoms of discomfort 
during hypochlorite disinfection. The main complaints were 
conjunctival hyperemia (28.4%), followed by headache and 
Characterist
ic 
Period 
1 
Before 
Hypochl
orite 
Period 
2 
During 
Hypochl
orite 
Period 
3 
After 
Hypochl
orite 
P* 
Admissions 
(total) 
21726 5973 10114  
 Monthly 
average 
2173 1991 2023  
Number of 
culture 
    
 Total 12470 5232 7229  
 Positiives 
(%) 
27,4 26,0 25,0 0,92 
 Acinetobac
ter 
/positives 
(%)  
9,3 6,3 8,8 0,62 
Acinetobacter 
infections (per 
1000-patient-
days) 
    
 Total 16,7 5,1 25,0 <0.05 
 Urinary 
tract 
4,3 1,1 12,0 <0.05 
 Ventilator 
associated 
pneumonia 
8,1 4,0 6,5 <0.05 
 Bacteremia 4,6 1,1 3,4 <0.05 
Acinetobacter 
colonization 
(per 1000-
patient-days) 
    
 Total 57,0 56,4 55,1 0,96 
* p < 0,05 comparing the period 2 with periods 1 and 3. 
Periods 1 and 3 were similar 
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smell (27.8 and 22.4%, respectively). All side effects are 
depicted in Table 2. 
Table 2. Side effects in healthcare workers during 
environmental hygienization with sodium hypochlorite 
Side	  effects	  (n=197)	   n	   %	  
Healthcare	  worker	  without	  
complaints	  
24	   12,2%	  
Conjuntival	  hyperemia	   56	   28,4%	  
Headache	   54	   27,4%	  
Smell	   45	   22,8%	  
Cough	   31	   15,7%	  
Nasal	  discharge	   24	   12,2%	  
Dizzness	   15	   7,6%	  
Nasal	  hyperemia	   11	   5,6%	  
Dry	  mouth	   4	   2,0%	  
Malaise	   3	   1,5%	  
Dyspnea	   3	   1,5%	  
Other	   7	   3,6%	  
 
DISCUSSION  
	  
We demonstrated that an isolated intervention for 
environmental hygienization could reduce the rate of 
Acinetobacter infection. The effect of this intervention was 
significant but was not sustained for more than three 
months. The failure in sustained control of infection can be 
explained by several reasons. The first is that we employed 
an isolated measure to control infection, instead of 
including a cohort, continuous education about infection 
control and hand hygiene, orientation about ideal contact 
isolation to prevent infection or other programs. A second 
reason is the maintenance of colonized patients. Active 
surveillance of colonization was not performed. Patients 
colonized with Acinetobacter have prolonged 
hospitalization, several complications and invasive 
procedures (broncoscopy, endoscopy, curatives) and are 
subjected to radiological exams that require transportation. 
All of these conditions favor dissemination of Acinetobacter 
and persistence on objects and surfaces. Studies have 
demonstrated that Acinetobacter can survive on dry 
surfaces for more than three months9,10. In our institution, 
the polyclonal presence of Acinetobacter also contributes 
to the permanence in the environment, which is related to 
the endemic condition of this microorganism. 
 
Figure 2. Dendogram of Acinetobacter strains isolated 
from patients with bacteremia. (3 and 5 -   blood; 1,8 
and 11 – catheter t ip),  showing the polyclonal pattern, 
suggesting the endemic characterist ic in the institution. 
 
A previous study showed a seasonal variance in 
Acinetobacter infection10,11. In our institution, we did not 
observe this tendency. We performed a retrospective 
analysis on the four years prior to this intervention and 
observed that the rate of infection was not affected by 
climate variance (data not shown). Observational studies 
suggested that environment plays a significant role for 
transmission of nosocomial pathogens, including 
Acinetobacter baumannii11,12. Nevertheless, unsanitary 
hands of healthcare workers are the main cause of 
transmission12,13. 
Our study supports current guidelines that 
recommend disinfection of surfaces in specific patient-care 
areas in order to reduce the risk of nosocomial pathogen 
transmission from surfaces9,10. The use of sodium 
hypochlorite for environmental cleaning has been 
demonstrated in several publications13-16. Other products 
have been tested for their effectiveness, including 
quaternary ammonium compound13-16. Apisarnthanarak et 
al. showed a lower level of Acinetobacter infection, which 
was sustained, during a year in intensive care units. These 
authors included other approaches as well as educational 
measures. Our study evaluated the isolated use of 
environmental disinfection, without other measures, and 
we also evaluated the entire hospital. 
The use of the sodium hypochlorite had several 
adverse effects in the hygiene team as well as in patients 
and healthcare workers. Apisarnthanarak et al. 
discontinued the use of hypochlorite due to adverse 
effects, and we evaluated the major complaints. 
Conjunctival hyperemia was the most common side effect, 
but all healthcare workers exposed to hypochlorite 
reclaimed the modification in environmental disinfection. 
Furthermore, we did not observe any absences in 
healthcare workers during disinfection. We believe that 
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sodium hypochlorite can be used as a measure 
periodically, but not as a normal routine. It should be more 
emphasized that potentially staff compliance to infection 
control procedures could have been influenced during the 
hypochlorite phase.     
 
CONCLUSION  
	  
The conclusion of this study is that environment 
hygienization with hypochlorite is safe and effective in 
controlling endemic Acinetobacter infection. However, this 
isolated approach is not sustained and must be performed 
in conjunction with other measures of infection control. 
Adverse effects caused by hypochlorite usage are transitory 
and does not result in absenteeism of healthcare workers. 
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